SABLE INTERIORS LIMITED

Financial Health Score: D+

Explanation: Sable Interiors Limited is suffering from a severe depletion of its overall structural reserves (net assets), which have plummeted by 87% in just one year. While the company has successfully treated its short-term liquidity issues—moving into positive working capital—the long-term financial skeleton (fixed assets) has been drastically diminished. The ongoing extraction of funds via a director's loan further restricts the company's ability to build resilience. The patient is surviving but is highly vulnerable to future economic shocks.

1. Key Vital Signs

• Net Assets (Overall Blood Pressure): £18,384
  • Interpretation: Dangerously low. This is a dramatic fall from £141,838 in 2023 and an even steeper drop from a historical high of £261,322 in 2017. The company’s overall equity reserve is dangerously thin, leaving very little margin for error if trade dips.
• Working Capital / Net Current Assets (Short-Term Pulse): £27,319
  • Interpretation: Healthy improvement. In 2023, the company had negative working capital (-£76,565), meaning it owed more in short-term debts than it had in short-term assets—a classic symptom of potential insolvency. In 2024, this has swung to a positive £27,319, meaning the company can comfortably cover its immediate liabilities.
• Fixed Assets (Structural Bone Density): £14,889
  • Interpretation: Severe deterioration. Fixed assets dropped from £247,801 in 2023 to just £14,889 in 2024. This represents a major sell-off or write-down of long-term assets.
• Current Liabilities (Short-Term Debt Burden): £203,412
  • Interpretation: Improving, but still high. The company reduced its short-term creditors from £307,449 to £203,412. This reduction aligns with the drop in fixed assets, suggesting assets were sold to pay down urgent debts.
• Director's Loan (Internal Blood Flow): £29,066 owed by the director
  • Interpretation: Drain on resources. The director owes the company nearly £30,000, an increase from £24,379 the previous year. While the director previously repaid a larger loan (£45k down to £24k), this new borrowing extracts vital cash from the business.

2. Symptoms Analysis

The financial data reveals a company that has undergone a major "asset stripping" or restructuring procedure over the last year:

• The Asset Liquidation Symptom: The near-total disappearance of fixed assets (down from £247k to £14k) strongly suggests the company sold off significant property, equipment, or investments. The proceeds were used to clear a large portion of short-term creditors (which dropped by over £100k) and boost current assets. This is akin to selling off the family silver to pay off urgent credit card bills—it solves the immediate cash crisis but leaves the business with no long-term asset base.
• The Weight Loss Trend: Looking at the 10-year history, the company’s net assets have been on a steady downward trajectory since 2017 (£261k). The brief recovery in 2023 (up to £141k from £54k in 2022) now appears to have been an anomaly or a reclassification of assets rather than sustainable organic growth.
• Staffing Reduction: The average number of employees dropped from 8 to 7, indicating a slight contraction of the business's operational capacity.

3. Diagnosis

Diagnosis: Acute Structural Depletion with Stabilized Short-Term Liquidity

The patient has survived an immediate liquidity crisis (curing the negative working capital of 2023), but the treatment has left the business fundamentally weakened. By liquidating fixed assets to pay off pressing current liabilities, Sable Interiors has traded long-term health for short-term survival.

With net assets of just £18,384, the company has almost no financial "immune system". If current assets (like debtors or stock) fail to materialize as cash, or if trade drops off, the company could quickly slip back into negative working capital and potential insolvency. Furthermore, the director's loan of £29,066 represents a significant portion of the company's already meager net assets, meaning capital that could be used to stabilize the business is currently tied up in the director's personal finances.

4. Recommendations

To restore the company to full financial health, the following prescribed actions are recommended:

1. Repay the Director's Loan: The £29,066 owed by the director should be repaid to the company as a matter of priority. This will inject much-needed cash into current assets, bolstering the company's fragile working capital and providing a buffer against future trading uncertainties.
2. Protect the Working Capital: Having fought to achieve positive working capital (£27,319), the business must guard it fiercely. Avoid taking on new short-term debts unless absolutely necessary, and ensure current assets (like stock and debtors) are converted to cash efficiently.
3. Investigate the Asset Decline: The director must assess whether the depletion of fixed assets is a permanent shift in the business model (e.g., transitioning from an asset-heavy to an asset-light/outsourced model) or a one-time emergency measure. If the business still requires fixed assets to operate, a plan must be made to gradually rebuild them without taking on unmanageable debt.
4. Rebuild Equity Reserves: With net assets at a perilously low £18k, the company must focus on profitability. Retained profits must be allowed to accumulate to rebuild the equity buffer. The director should refrain from extracting dividends until the net asset base returns to a healthier threshold (e.g., above £50k).